Hematuria clinical trials

The registry lists 67 studies for Hematuria across more than 10 countries. 18 are recruiting or about to start. 37 of them are mainly about Hematuria (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Hematuria studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 29
Status unknown: 11
Recruiting: 10
Not yet recruiting: 7
Terminated: 5
Active, not recruiting: 3

Phase

Phase 2: 5
Phase 4: 5
Phase 3: 4
Early Phase 1: 1
Phase 1: 1

Where

United States: 20
Canada: 6
France: 5
Turkey: 4
China: 3
Egypt: 3

Who runs them

Changhai Hospital (3) · NYU Langone Health (2) · National and Kapodistrian University of Athens (2) · British Urology Researchers in Surgical Training (2) · Pacific Edge Limited (2) · Mansoura University (2) · Fraser Health (1) · Marmara University (1)

What is being tested here

Drugs under test in Hematuria studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Furosemide	1	1	1
Lidocaine	0	1	2
Diclofenac	0	0	2
Tranexamic Acid	0	0	1
Valproic Acid	0	0	1
Water	0	0	1
Praziquantel	0	0	1
Aspirin	0	0	1
Finasteride	0	0	1
Estradiol Vaginal Ring	0	0	1

Drug classes tested here NSAIDs 3

Coming up

2phase 3 studies under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Mar 2027Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases · Pangea Laboratory LLC
Apr 2027Bladder Cancer Screening Trial · University of Texas Southwestern Medical Center

Who these studies take

Of the 10 Hematuria studies recruiting now, 7 (70%) set no upper age limit and 1 (10%) stop at 75 or younger. 2 (20%) take children under 18. 1 (10%) are for women only and 1 (10%) for men only; 2 (20%) take healthy volunteers.

Recruiting studies that take each age, of 10
Age	Women	Men
10	2 (20%)	2 (20%)
18	5 (50%)	5 (50%)
30	5 (50%)	5 (50%)
40	6 (60%)	6 (60%)
50	8 (80%)	8 (80%)
65	8 (80%)	8 (80%)
75	8 (80%)	8 (80%)
85	8 (80%)	8 (80%)

Across all 67 studies, recruiting or not: 10% stop at 75 or younger and 9% at 65; 18% take children; 9% are for women only and 15% for men only; 22% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 67. Browse all 67 → or search them.